COVID-19

In a freewheeling conversation, Leena Menghaney, Regional Head, MSF Access Campaign explains to Viveka Roychowdhury how the Covid…

The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…

There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…

Compared to other researched markets (France, Germany, Italy, Spain, the UK and Japan), the US respondents reported the highest…

The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…

Dr Sanjay Kumar Jain, President - India Operations, Amneal Pharmaceuticals speaks about the emerging trends in pharma R&D,…

The study is currently the only one in the world that monitored the population for more than a year, taking into account numerous…

Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…

CORBEVAX is expected to be available as a Booster dose on the CoWIN App in public and private vaccination centres from August 12,…

Vaccine Track data insights revealed sustained decline of recommended adult immunisations, excluding flu vaccinations, across the…